GILD - mid term strong

Whilst the main market settled moderately mixed, there was notable strength in Gilead Sciences (GILD), which settled +2.2% at $75.88. The Nov' low of $70.05 marks a key higher low. M/t outlook is bullish to >90.


GILD daily

GILD monthly

Summary

Suffice to add, the recent Nov' low of $70.05, marks a key higher low. Price structure on the monthly chart is a bull flag spanning Sept-Nov'. A break into the 77s would arguably provisionally confirm it, the 86s would be decisive.

First target is the $90 threshold, back to levels from April 2016. Bullish GILD into/across 2018.